The Patients' and Consumers' Working Party (PCWP) provides a platform for exchange of information and discussion of issues of common interest between EMA and patients and consumers.
The PCWP, established in 2006, has enabled the Agency to build upon its existing interactions with patients and consumers. It provides recommendations to EMA and its human scientific committees on all matters of interest in relation to medicines.
The following documents provide information on the PCWP's responsibilities and composition:
The PCWP consists of:
- a core group of representatives from the eligible patients' and consumers' organisations;
- representatives from EMA's scientific committees;
- observers from:
The members' declarations of interests are available in the European experts list.
|EMA||Juan Garcia Burgos|
|European Patients' Forum (EPF)||Kaisa Immonen|
Organisation representative members
Members representing EMA's scientific committees
|Committee for Advanced Therapies|
Michelino Lipucci di Paola
|Committee for Medicinal Products for Human Use|
Concepcion Prieto Yerro
|Committee for Orphan Medicinal Products||Daniel O'Connor|
|Committee on Herbal Medicinal Products|
Gunter Karl-Heinz Auerswald
|Pharmacovigilance Risk Assessment Committee|
Albert van der Zeijden
EMA Management Board
Yann Le Cam
|Healthcare Professionals Working Party||Donald Singer|
|European Commission (DG SANTE)||Rotating membership|
How useful is this page?
Average rating:Based on 6 ratings
Add your rating:
- See all ratings
1 ratings0 ratings0 ratings0 ratings5 ratings